Health decision-making needs technical evaluation support urgently

Source: Health News 2015-11-03 (reporter Wu Weihong) recently, the 9th China Health Technology Evaluation forum was held in Shanghai by Fudan University pharmacoeconomics research and evaluation center and Fudan University School of public health Experts at the meeting pointed out that China's health technology assessment is not fully carried out, and its policy transformation is even more limited It is urgent to establish a third-party evaluation mechanism to provide basis for government decision-making According to reports, health technology assessment is a relatively new field, which is to assess the effectiveness, safety, economy, ethics and social impact of health technology The assessment objects include medical devices, drugs, technical service programs, etc Many countries have independent health technology assessment institutions supported by the government to provide basis for government decision-making Professor Chen yingyao, vice president of School of public health, Fudan University, pointed out that China has not yet established the organizational system and working mechanism of health technology assessment, nor has it been systematically integrated into the decision-making process Relevant government departments are seriously divided, and there are many difficulties in the coordination and connection of different departments At present, technology selection and decision-making mainly rely on experts and experience, while the refined evaluation is almost blank He suggested that China should learn from foreign experience and gradually establish a third-party evaluation mechanism Duan Zhengming, director of the medical service management department of the social security center of the Ministry of human resources and social security, said that with the aging of the population, the change of disease spectrum and the development of new medical technology, medical insurance is facing great pressure Patients want to spend less, hospitals want to collect money, health insurance needs to spend money, and health technology assessment needs to play a more important role in balancing the relationship between the three He suggested that health technology assessment should be based on evidence-based research, open and transparent to the society, and provide access and payment standards starting from drugs of wide concern to the society Scholars from Canada, the United States, France, Australia, New Zealand and nearly 300 domestic researchers and policy makers attended the meeting.